These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1808151)

  • 1. Results of the phase III trials with Imagent GI as an oral magnetic resonance contrast agent.
    Mattrey RF; Trambert MA; Brown JJ; Bruneton JN; Young SW; Schooley GL
    Invest Radiol; 1991 Nov; 26 Suppl 1():S65-6; discussion S71. PubMed ID: 1808151
    [No Abstract]   [Full Text] [Related]  

  • 2. Blackberry (Rubus spp.): a pH-dependent oral contrast medium for gastrointestinal tract images by magnetic resonance imaging.
    Espinosa MG; Sosa M; De León-Rodríguez LM; Córdova T; Bernal-Alvarado J; Avila-Rodríguez M; Reyes-Aguilera JA; Ortíz JJ; Barrios FA
    Magn Reson Imaging; 2006 Feb; 24(2):195-200. PubMed ID: 16455409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastrointestinal contrast agents for MR imaging.
    Brown JJ
    Magn Reson Imaging Clin N Am; 1996 Feb; 4(1):25-35. PubMed ID: 8673714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Oral magnetic particles as an MR contrast medium for the gastrointestinal tract].
    Rinck PA; Myhr G; Smevik O; Børseth A
    Rofo; 1992 Dec; 157(6):533-8. PubMed ID: 1457787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization and mechanism of side-effects of Imagent BP (highly concentrated fluorocarbon emulsion) in swine.
    Flaim SF; Hazard DR; Hogan J; Peters RM
    Invest Radiol; 1991 Nov; 26 Suppl 1():S122-4; discussion S125-8. PubMed ID: 1808107
    [No Abstract]   [Full Text] [Related]  

  • 6. [New oral contrast material for gastrointestinal MR examination--green tea mixed with sodium alginate].
    Hasegawa M; Kubota H; Kitanosono T; Ri K; Munechika H
    Nihon Igaku Hoshasen Gakkai Zasshi; 1990 Jan; 50(1):79-80. PubMed ID: 2330290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MR imaging of the gastrointestinal tract with i.v., gadolinium and diluted barium oral contrast media compared with unenhanced MR imaging and CT.
    Low RN; Francis IR
    AJR Am J Roentgenol; 1997 Oct; 169(4):1051-9. PubMed ID: 9308464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contemporary and emerging technologies in abdominal magnetic resonance imaging.
    Liu PS; Hussain HK
    Semin Roentgenol; 2013 Jul; 48(3):203-13. PubMed ID: 23796371
    [No Abstract]   [Full Text] [Related]  

  • 9. Particulate oral NMR contrast agents.
    Runge VM; Foster MA; Clanton JA; Smith FW; Lukehart CM; Hutchison JM; Mallard JR; Partain CL; James AE
    Int J Nucl Med Biol; 1985; 12(1):37-42. PubMed ID: 4008165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perflexane (AF0150, AFO 150, Imagent, Imavist).
    Drugs R D; 2002; 3(5):306-9. PubMed ID: 12455151
    [No Abstract]   [Full Text] [Related]  

  • 11. Euterpe Olerácea (Açaí) as an alternative oral contrast agent in MRI of the gastrointestinal system: preliminary results.
    Córdova-Fraga T; de Araujo DB; Sanchez TA; Elias J; Carneiro AA; Brandt-Oliveira R; Sosa M; Baffa O
    Magn Reson Imaging; 2004 Apr; 22(3):389-93. PubMed ID: 15062934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic resonance contrast agents for medical and molecular imaging.
    Allen MJ; Meade TJ
    Met Ions Biol Syst; 2004; 42():1-38. PubMed ID: 15206098
    [No Abstract]   [Full Text] [Related]  

  • 13. [Oral contrast media for magnetic resonance tomography of the abdomen. III. Initial patient research with gadolinium-DTPA].
    Claussen C; Kornmesser W; Laniado M; Kaminsky S; Hamm B; Felix R
    Rofo; 1988 Jun; 148(6):683-9. PubMed ID: 2837806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro evaluation of alternative oral contrast agents for MRI of the gastrointestinal tract.
    Babos M; Schwarcz A; Randhawa MS; Marton B; Kardos L; Palkó A
    Eur J Radiol; 2008 Jan; 65(1):133-9. PubMed ID: 17485189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase III trial of oral magnetic particles in MRI of abdomen and pelvis.
    MacVicar D; Jacobsen TF; Guy R; Husband JE
    Clin Radiol; 1993 Mar; 47(3):183-8. PubMed ID: 8472481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perflubron as an oral contrast agent for MR imaging: results of a phase III clinical trial.
    Mattrey RF; Trambert MA; Brown JJ; Young SW; Bruneton JN; Wesbey GE; Balsara ZN
    Radiology; 1994 Jun; 191(3):841-8. PubMed ID: 8184076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Oral contrast media for the magnetic resonance tomography of the abdomen. A clinical trial of the tolerance for gadolinium-DTPA].
    Kaminsky S; Laniado M; Gogoll M; Kornmesser W; Clauss W; Felix R
    Rofo; 1992 Jan; 156(1):17-23. PubMed ID: 1733470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MRI agents for abdomen offer high sensitivity.
    D'Agincourt L
    Diagn Imaging (San Franc); 1992 Aug; 14(8):78-85. PubMed ID: 10147536
    [No Abstract]   [Full Text] [Related]  

  • 19. Magnetic resonance imaging of the gut: a primer for the luminal gastroenterologist.
    Romero M; Buxbaum JL; Palmer SL
    Am J Gastroenterol; 2014 Apr; 109(4):497-509; quiz 510. PubMed ID: 24394750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in contrast-enhanced MR imaging. Gastrointestinal contrast agents.
    Hahn PF
    AJR Am J Roentgenol; 1991 Feb; 156(2):252-4. PubMed ID: 1898795
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.